Showing results 1 to 20 of 27
next >
| Issue Date | Title | Author(s) |
| 2022-06-01 | Australian innovation: Patent database construction and first evidence | Bedford, A; Ma, L; Ma, N; Vojvoda, K |
| 2022-11-25 | Australia’s Aged Care Sector: Full-Year Report (2021–22) | Sutton, N; Ma, N; Yang, JS; Lewis, R; Brown, D; Woods, M; McEwen, C; Parker, D |
| 2023-12-07 | Australia’s Aged Care Sector: Full-Year Report (2022–23) | Sutton, N; Ma, N; Yang, JS; Lewis, R; Woods, M; Tsihlis, E; Lin, J; Parker, D |
| 2022-05-17 | Australia’s Aged Care Sector: Mid-Year Report (2021-22) | Sutton, N; Ma, N; Yang, J; Lewis, R; McAllister, G; Brown, D; Woods, M |
| 2023-05-31 | Australia’s Aged Care Sector: Mid-Year Report (2022–23) | Sutton, N; Ma, N; Yang, J; Lewis, R; Woods, M; Ries, N; Parker, D |
| 2024-06-20 | Australia’s Aged Care Sector: Mid-Year Report 2023–24 | Sutton, N; Ma, N; Yang, JS; Woods, M; Tsihlis, E; Brown, D; Debono, D; Ries, N |
| 2023-10-01 | CEO power and the strategic selection of accounting financial experts to the audit committee | Bedford, A; Ghannam, S; Grosse, M; Ma, N |
| 2023-08-02 | CEO power and the strategic selection of accounting financial experts to the audit committee | Bedford, A; Ghannam, S; Grosse, M; Ma, N |
| 2023 | Compartmentalized spatial profiling of the tumor microenvironment in head and neck squamous cell carcinoma identifies immune checkpoint molecules and tumor necrosis factor receptor superfamily members as biomarkers of response to immunotherapy. | Sadeghirad, H; Liu, N; Monkman, J; Ma, N; Cheikh, BB; Jhaveri, N; Tan, CW; Warkiani, ME; Adams, MN; Nguyen, Q; Ladwa, R; Braubach, O; O'Byrne, K; Davis, M; Hughes, BGM; Kulasinghe, A |
| 2020-04 | The consequences of discount rate selection for defined benefit liabilities | Fahad, N; Ma, N; Scott, T |
| 2021-10-05 | Considering the new minimum staffing standards for Australian residential aged care. | Sutton, N; Ma, N; Yang, JS; Rawlings-Way, O; Brown, D; McAllister, G; Parker, D; Lewis, R |
| 2018-06-01 | Cost-effective imaging for resectability of liver lesions in colorectal cancer: an economic decision model | Saing, S; Haywood, P; Duncan, JK; Ma, N; Cameron, AL; Goodall, S |
| 2020-02-01 | Evidence on compensation consultant fees and CEO pay | Grosse, M; Ma, N; Scott, T |
| 2020-02-01 | Evidence on compensation consultant fees and CEO pay | Grosse, M; Ma, N; Scott, T |
| 2017-06-26 | Evidence on compensation consultant fees and CEO pay in a mandatory disclosure setting | Grosse, M; Ma, N; Scott, T |
| 2019-06-01 | Further evidence on mandatory partner rotation and audit pricing: a supply-side perspective | Ferguson, A; Lam, P; Ma, N |
| 2021-01 | Future profitability and stock returns of innovative firms in Australia | Bedford, A; Ma, L; Ma, N; Vojvoda, K |
| 2021-01-22 | Future profitability and stock returns of innovative firms: a pitch | Bedford, A; Ma, L; Ma, N; Vojvoda, K |
| 2018-04-06 | Interim reviews and the association between partner rotations and audit fees | Grosse, M; Ma, N; Scott, T |
| 2018-08-01 | Market reactions to auditor switches under regulatory consent and market driven regimes | Ferguson, A; Lam, P; Ma, N |
